FDA Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of FDA Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Arthritis Vaccines
Research on arthritis vaccines published by scientists at JiaoTong University, Shanghai Institute of Immunology
March 15th, 2007
Scientists discuss in "Vaccination with selected synovial T cells in rheumatoid arthritis" new findings in arthritis. According to recent research from Shanghai, People's Republic of China, "This pilot clinical study was undertaken to investigate the role of T cell vaccination in the induction of regulatory immune responses in patients with rheumatoid arthritis (RA). Autologous synovial T cells were selected for pathologic relevance, rendered inactive by irradiation, and used for vaccination." "Fifteen patients received T cell vaccination via 6 subcutaneous inoculations over a period of 12 months. T cell vaccination led to induction of CD4+ Tregs and CD8+ cytotoxic T...
Source: FDA Law Weekly (2007-03-15)
|
